Valsartan-Induced Angioedema
- 1 July 2003
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 37 (7), 1024-1027
- https://doi.org/10.1345/aph.1c520
Abstract
OBJECTIVE: To report a case of dose-dependent angioedema secondary to the use of the angiotensin-receptor blocker (ARB) valsartan. CASE SUMMARY: A 64-year-old Hispanic woman presented with swelling of the lips shortly after an increase in her valsartan dose for uncontrolled hypertension. Other potential causes were not identified. The angioedema subsequently resided after a dosage reduction and observation. Use of the Naranjo probability scale indicated a probable relationship between the angioedema and valsartan therapy in this patient. DISCUSSION: Drug-induced angioedema is often associated with the use of angiotensin-converting enzyme (ACE) inhibitors and is probably secondary to their effects on bradykinin levels. ARBs are thought to produce few, if any, cases of angioedema if excess bradykinin levels are the root cause of angioedema secondary to ACE inhibitor use. Several potential ARB-induced cases of angioedema have been reported. The exact mechanism of angioedema induced by drugs in both of these classes is unknown. Animal data suggest that there may be a relationship between ARB use and increased tissue bradykinin levels secondary to stimulation of angiotensin II AT2 receptors. CONCLUSIONS: This is the third reported case of valsartan-induced angioedema and the first thought to be dose dependent. Practitioners should be aware of this potential adverse effect of valsartan, although the underlying cause is still not known.Keywords
This publication has 20 references indexed in Scilit:
- Angioedema Associated With Angiotensin II Receptor Antagonists: Challenging Our Knowledge of Angioedema and Its EtiologyThe Laryngoscope, 2001
- Hypertension and DiabetesArchives of Internal Medicine, 2000
- Losartan-Induced AngioedemaAnnals of Pharmacotherapy, 1999
- ACE Inhibitor—Versus Angiotensin II Blocker–Induced Cough and AngioedemaAnnals of Pharmacotherapy, 1998
- Accupril- and Cozaar-induced angioedema in the same patientJournal of Allergy and Clinical Immunology, 1996
- Angioedema Induced by the Angiotensin II Blocker LosartanNew England Journal of Medicine, 1995
- Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive PatientsHypertension, 1995
- Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human ForearmJournal of Cardiovascular Pharmacology, 1993
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyAnnals of Internal Medicine, 1992